The story of Viagra, formerly marketed by copyright, presents a complex case study for backers considering the healthcare sector. Although its early success and generation of billions in revenue , the exclusivity lapse has opened the door for generic medications, greatly diminishing income prospects . This change raises questions about the long-ter